Get Live Data

Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada
Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in CanadaView Video
Roundtable Discussion; The Future of Mineral Sands
Roundtable Discussion; The Future of Mineral SandsView Video

Latest Share Chat

  2. Share Prices
  3. Avacta Group Share Price
  4. Avacta Group Share News
  5. UK earnings, trading statements calendar - next 7 days

Pin to quick picksAvacta Group Share News (AVCT)

Avacta Group Information

Share Price Information for Avacta Group (AVCT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 45.75
Bid: 45.50
Ask: 46.00
Change: -1.00 (-2.14%)
Spread: 0.50 (1.099%)
Open: 45.75
High: 46.25
Low: 45.50
Prev. Close: 46.75
AVCT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK earnings, trading statements calendar - next 7 days

Thu, 15th Apr 2021 14:56

Friday 16 April 
Ashmore Group PLCTrading Statement
Essentra PLCQ1 Results
Foxtons Group PLCTrading Statement
Mediclinic International PLCTrading Statement
Monday 19 April 
Churchill China PLCFull Year Results
Energean PLCFull Year Results
GB Group PLCTrading Statement
Tuesday 20 April 
Avast PLCQ1 Results
Associated British Foods PLCHalf Year Results
Card Factory PLCFull Year Results
City of London Investment Group PLCTrading Statement
Discoverie Group PLCTrading Statement
Filta Group Holdings PLCFull Year Results
Flowtech Fluidpower PLCFull Year Results
Jupiter Fund Management  PLCTrading Statement
MaxCyte IncFull Year Results
Moneysupermarket.com Group PLCTrading Statement
Porvair PLCTrading Statement
RBG Holdings PLCFull Year Results
Rio Tinto PLCQ1 Operations Review
Wednesday 21 April 
Antofagasta PLCQ1 Production Results
BHP Group PLCQ1 Operations Review
Bunzl PLCQ1 Results
Carr's Group PLCHalf Year Results
Distribution Finance Capital Holdings PLCFull Year Results
Hochschild Mining PLCQ1 Production Results
Hunting PLCTrading Statement
Kier Group PLCHalf Year Results
Pennant International Group PLCFull Year Results
Polymetal International PLCQ1 Production Results
Quilter PLCTrading Statement
Wentworth Resources PLCFull Year Results
Thursday 22 April 
AJ Bell PLCTrading Statement
Anglo American PLCQ1 Production Results
Avacta Group PLCfull Year Results
BlackRock Greater Europe Investment Trust PLCHalf Year Results
Centamin PLCQ1 Production Results
Deltex Medical Group PLCFull Year Results
Domino's Pizza Group PLCTrading Statement
GB Group PLCTrading Statement
Gem Diamonds LtdTrading Statement
Ibstock PLCTrading Statement
Informa PLCFull Year Results
Jadestone Energy IncFull Year Results
Rentokil Initial PLCTrading Statement
RWS Holdings PLCTrading Statement
Segro PLCTrading Statement
Taylor Wimpey PLCTrading Statement
Trifast PLCTrading Statement
  
Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
15 Dec 2021 08:24

Avacta antigen lateral flow test shown to detect Omicron

(Sharecast News) - Aim-listed Avacta said on Wednesday that its AffiDX® antigen lateral flow test has been shown to detect the Omicron variant of the SARS-CoV-2 virus in clinical samples.

Read more
29 Nov 2021 11:07

IN BRIEF: Avacta gets FDA nod to expand cancer drug trial into US

IN BRIEF: Avacta gets FDA nod to expand cancer drug trial into US

Read more
29 Nov 2021 10:38

FDA gives Avacta the go-ahead for US chemotherapy trials

(Sharecast News) - Clinical-stage biopharmaceutical company Avacta Group announced on Monday that the US Food and Drug Administration (FDA) has approved its investigational new drug (IND) application for its chemotherapy drug 'AVA6000'.

Read more
2 Nov 2021 11:25

Avacta and Novacyt await UK regulatory approval for Covid-19 tests

Avacta and Novacyt await UK regulatory approval for Covid-19 tests

Read more
2 Nov 2021 10:21

Avacta suspends UK Covid test sales ahead of new approval

(Sharecast News) - Avacta said on Tuesday that it has suspended sales of its AffiDX Covid latest flow rapid antigen tests in the UK while it awaits new approval.

Read more
30 Sep 2021 11:14

Avacta hails "transformative" first half despite widening loss

Avacta hails "transformative" first half despite widening loss

Read more
30 Sep 2021 09:27

Avacta losses widen as development spend increases

(Sharecast News) - Clinical-stage biopharmaceutical company Avacta Group reported cash and short-term deposits of £37m at the end of its first half on Thursday, down from £54.5m a year ago and £47.9m at the start of the period.

Read more
29 Sep 2021 10:32

Avacta sees pre-clinical development milestone in LG Chem partnership

Avacta sees pre-clinical development milestone in LG Chem partnership

Read more
29 Sep 2021 09:26

Avacta gets undisclosed milestone payment from LG Chem

(Sharecast News) - Clinical-stage biopharmaceutical company Avacta Group announced on Wednesday that a preclinical development milestone has been achieved in its multi-target therapeutics partnership with South Korea's LG Chem Life Sciences, triggering an undisclosed milestone payment.

Read more
23 Sep 2021 15:59

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
2 Sep 2021 11:50

IN BRIEF: Avacta hires oncology drug developer as therapeutics CSO

IN BRIEF: Avacta hires oncology drug developer as therapeutics CSO

Read more
18 Aug 2021 14:26

IN BRIEF: Avacta hires cancer doctor Mark Goldberg for board

IN BRIEF: Avacta hires cancer doctor Mark Goldberg for board

Read more
11 Aug 2021 11:29

Avacta doses first patient in chemotherapy medication trial

Avacta doses first patient in chemotherapy medication trial

Read more
11 Aug 2021 10:00

First patient dosed in Avacta's 'AVA6000' trial

(Sharecast News) - Clinical-stage oncology drug company Avacta Group announced on Wednesday that the first patient has been dosed in its phase 1 multicentre trial evaluating 'AVA6000', which it described as a "novel pro-drug" of 'doxorubicin', and its first therapeutic product based on the proprietary 'preCISION' technology.

Read more
4 Aug 2021 17:53

IN BRIEF: Shipment of Avacta's Covid-19 lateral flow test starts

IN BRIEF: Shipment of Avacta's Covid-19 lateral flow test starts

Read more
34567891011

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.